Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113356 | 1.00 | KMT2A (0.52) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL4320902 | 1.00 | KMT2A (0.52) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL4652789 | 1.00 | KMT2A (0.52) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL7908817 | 0.92 | KMT2A (0.42) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL24035227 | 0.92 | CA1 (0.46) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL25796666 | 0.90 | CA1 (0.45) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL14334895 | 0.90 | CA1 (0.45) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL14334894 | 0.90 | CA1 (0.45) | KMT2ACA1CA2CA4MKNK2 | |
| SCHEMBL14377505 | 0.86 | CA1 (0.42) | KMT2ACA1CA2CA4ALDH1A1 | |
| SCHEMBL7524222 | 0.84 | KMT2A (0.63) | KMT2ACA1CA2CA4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3197510-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | The Procter & Gamble Company (US) | 2017-08-02 | — | — | EP | claimed |
| WO-2016049458-A1 | DELIVERY SYSTEMS COMPRISING MALODOR REDUCTION COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2016-03-31 | — | — | WO | claimed |
| US-7615526-B2 | Furanoid and pyranoid C14-C18- oxabicycloalkanones as odoriferous and/or aroma substances | SYMRISE GMBH & CO. KG (DE) | 2009-11-10 | — | — | US | disclosed |
| US-20080234174-A1 | FURANOID AND PYRANOID C14-C18- OXABICYCLOALKANONES AS ODORIFEROUS AND/OR AROMA SUBSTANCES | SYMRISE GMBH & CO. KG (DE) | 2008-09-25 | — | — | US | disclosed |
| EP-1972632-A1 | Oxabicycloalkanones as fragrances | Symrise GmbH & Co. KG (DE) | 2008-09-24 | — | — | EP | disclosed |
| WO-2003037841-A1 | MIXTURES FOR USE AS MUSK FRAGRANCE | SYMRISE GMBH & CO. KG (DE) | 2003-05-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234174-A1 | FURANOID AND PYRANOID C14-C18- OXABICYCLOALKANONES AS ODORIFEROUS AND/OR AROMA SUBSTANCES | CYP19A1, OXER1, AKR1C4 | KMT2A 1927/4885CA1 412/4885CA2 2864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.